まとめ
感受性の高い3T3線維芽細胞は,成長が停止したときに脂肪細胞に微分化します. 連続選択により,遺伝的変化が感受性に影響を与えるため,脂肪変換頻度が高いサブクローンを生成することができます.
科学分野:
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
背景:
- フィブロブラストがアディポサイトに分化することは,脂肪組織発達の重要なプロセスです.
- 3T3線維芽細胞は,アディポゲネシスを研究するためのモデルシステムとして機能します.
研究 の 目的:
- 3T3線維芽細胞における脂肪変換の頻度とメカニズムを調査する.
- アディポゲネシスの感受性における遺伝的変化の役割を調査する.
主な方法:
- 3T3ファイブロブラストの細胞培養.
- 脂肪変換頻度が異なるサブクローンの連続選択.
- 分化中の細胞形態の顕微鏡観察.
主要な成果:
- 感受性の高い3T3線維芽細胞は,成長停止時に脂肪細胞に微分化します.
- アディポース細胞形成はクラスターで発生し,クローン起源を示しています.
- 連続選択により,脂肪の変換頻度が大幅に増加したサブクローンが生成されました.
- トリグリセリド合成の調節を含む可能性が高い遺伝的変化が,感受性の増大の根底にある.
結論:
- 3T3線維芽細胞における脂肪酸変換は,細胞の感受性に影響する遺伝的要因の影響を受けます.
- 自発的,遺伝的変化は,強化されたアディポゲネシスにつながる可能性があります.
- 脂肪の変換プロセスは,トリグリセリドの蓄積と細胞の丸めを含む明確な形態学的変化を含みます.
さらに関連する動画
09:52Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System
Published on: January 6, 2023
2.3K
06:08Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
2.8K
関連する概念動画
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cellular Adaptation III: Hyperplasia
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
